Global IVD Market Analysis from 2022 to 2034 Containing Market Size, Share along with its CAGR, Forecast and Trends
Top Countries — Revenue
USD Million/Billion
Loading…
Share Distribution
Loading…
Access the full forecast model.
Country-level data · Company profiles · Editable dataset · Analyst consultation included.
Global IVD Market Analysis — Presence
Interactive World Map
Click countries to explore
Loading map…
Regional and Country Analysis
North America — United States, Canada, Mexico
Europe — United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Switzerland, Luxembourg, Rest of Europe
Asia Pacific — China, Japan, South Korea, India, Australia, Singapore, Taiwan, South East Asia, Rest of APAC
South America — Brazil, Argentina, Colombia, Peru, Chile, Rest of South America
Middle East — Saudi Arabia, Turkey, UAE, Egypt, Qatar, Rest of Middle East
Africa — East Africa, West Africa, North Africa, South Africa
Segmentation Analysis
Market size by (Illustrative, 2025)
Share distribution (2025)
Charts are illustrative — exact values, country-level breakdowns, and full forecast in the paid report. Request a Free Sample PDF.
To learn more about market share and segmentation, request the free sample pages.
Competitive Landscape of the Global IVD Market Analysis
In no particular order of rank
Company Profile:
bioMérieux SA
bioMérieux is specialized in offering in vitro diagnostics and molecular diagnostic solution in healthcare industries. The company offers several immunoassays, test, instrument for detection and diagnosis for infectious diseases, cancer, cardiac related conditon and other. The company offers system, reagents, software and services. The products offered in the portfolio are immunoassays, lab consultancy, microbiology, molecular diagnostics, and lab automation. Further, the company is also engaged in offering system services, laboratory and other services.
DiaSorin S.p.A
Dia Sorin S.p. A is specialized in offering laboratory diagnostic procedures under immunodiagnostic, molecular diagnostic segments. DiaSorin Molecular and Luminex Corporation is part of DiaSorin Group.The company delivers assays in the several areas such as infectious disease, oncology, stool diagnostic, autoimmunity, endocrinology, hypertension, and other. The company is engaged in development of CLIA, ELISA systems.
RECENT NEWS
July 2021
DiaSorin S.p.A has acquired Luminex Corporation
The company is engaged in acquisition with Luminex Corporation. This acquisition expanded the Luminex multiplexing technology and strengthen its presence in the U.S.
Click any bar or cell to request the full company profile
Company
2022 (A)
2023 (A)
2024 (A)
2025 (A)
Roche Diagnostics
•••
•••
•••
•••
Danaher Corporation
•••
•••
•••
•••
Abbott Laboratories
•••
•••
•••
•••
Siemens
•••
•••
•••
•••
Sysmex
•••
•••
•••
•••
Thermo Fisher Scientific
•••
•••
•••
•••
Becton Dickinson and Company
•••
•••
•••
•••
Biomrieux Sa
•••
•••
•••
•••
Bio Rad Laboratories
•••
•••
•••
•••
Johnson Johnson
•••
•••
•••
•••
Agilent Technologies
•••
•••
•••
•••
Qiagen
•••
•••
•••
•••
Diasorin
•••
•••
•••
•••
Ortho Clinical Diagnostics
•••
•••
•••
•••
Revenue data requires full access. *2nd & 3rd tier companies available on enquiry.
As per Cognitive Market Research's latest published report, the Global In Vitro Diagnostics market size will be $87,826.93 Million by 2028.In Vitro Diagnostics Industry's Compound Annual Growth Rate will be 4.48% from 2023 to 2030.
North America In Vitro Diagnostics market size will be USD 30,196.36 Million by 2028.
Introduction of In Vitro Diagnostics
A range of tools is used by health care practitioners to diagnose illnesses and guide treatment decisions. In-vitro diagnostics (IVDs), which are clinical tests that examine samples obtained from the human body, are among the most popular and commonly utilized.
In-vitro diagnostics are tests performed on samples obtained from the human body, such as blood or tissue. It can identify illnesses and other disorders, as well as monitor a person's general health to assist in the cure, treatment, or prevention of diseases.
IVDs are used to analyze human samples like blood and saliva, either by measuring the concentration of specific substances, or analytes (like sodium and cholesterol) or by detecting the presence or absence of a specific marker or set of markers, like a genetic mutation or an immune response to infection.
Precision medicine also employs in vitro diagnostics to identify patients who are likely to benefit from certain treatments or therapies. These in vitro diagnostics can involve next-generation sequencing tests, which analyze a person's DNA for genetic changes.
In-vitro diagnostics can be performed in laboratories, hospitals, or even at home. IVD tests are often conducted in a stand-alone laboratory, a hospital-based laboratory, or a point-of-care (POC) center, and typically comprise polymerase chain reaction (PCR), microarray methods, sequencing technologies, and mass spectrometry.
The tests themselves can be carried out on a wide range of tools, from simple portable devices to complicated laboratory equipment. It also made use of reagents that enable doctors to accurately diagnose patients and work to deliver suitable therapies.
Several businesses provide in vitro diagnostic services. The IVD can be used to manage infectious illnesses, cancer, cardiac diseases, immune system problems, nephrological diseases, gastrointestinal diseases, and many other conditions.
The Food and Drug Administration regulates these tests as medical devices, which means that before bringing them to market, producers must submit studies proving the test's accuracy and use in detecting a certain disease.
The need for speedy and accurate illness detection is growing, as are technological advances in IVD products and the use of point-of-care in-vitro diagnostics. Furthermore, the COVID-19 pandemic has altered the landscape of healthcare, causing seismic transformations in the IVD business. As a result, IVD is becoming more popular.
The Global In Vitro Diagnostics Market revenue in 2016: USD 57,688.56 Million
Reagents held for largest share of total revenue generated in 2019
Infectious Diseases held the maximum share of total revenue generated in 2019
Hospitals held the maximum share of total revenue generated in 2019
The growth in the geriatric population and rising prevalence of chronic diseases drives the growth of the invitro diagnostics market.
High cost of devices and unfavorable reimbursement scenarios may hamper the growth of market.
Investment in research and development of invitro diagnostics to satiate the ever-increasing demand of the diagnostic measures is expected to create lucrative opportunity for the invitro diagnostics market.
Analyst Conclusion
The Global In Vitro Diagnostics Market revenue in 2016: USD 57,688.56 Million
Reagents held for largest share of total revenue generated in 2019
Infectious Diseases held the maximum share of total revenue generated in 2019
Hospitals held the maximum share of total revenue generated in 2019
The growth in the geriatric population and rising prevalence of chronic diseases drives the growth of the invitro diagnostics market.
High cost of devices and unfavorable reimbursement scenarios may hamper the growth of market.
Investment in research and development of invitro diagnostics to satiate the ever-increasing demand of the diagnostic measures is expected to create lucrative opportunity for the invitro diagnostics market.
Supriya Yadav
Research Analyst at Cognitive Market Research · Cognitive Market Research
As a Research Analyst, I bring over two years of experience in market research, data analysis, and market estimation. I specialize in turning complex datasets into meaningful insights that help businesses identify opportunities, understand market dynamics, and make confident, growth-focused decisions.
My expertise spans across analyzing industry trends, forecasting market potential, mapping competitive landscapes, and studying consumer behavior to deliver actionable recommendations. With an MBA in Marketing and Finance, I combine strong analytical skills with strategic thinking, ensuring that every project I work on contributes real value to clients.
I am passionate about using research to uncover patterns, anticipate shifts, and deliver insights that drive measurable business impact. My goal is to continuously learn, innovate, and provide data-driven solutions that empower clients to succeed in a competitive environment.
The Global In Vitro Diagnostics Market size was valued at USD 3,889.76 Million in 2022.
Roche Diagnostics, Danaher Corporation, Abbott Laboratories, Siemens, Sysmex, Thermo Fisher Scientific, Becton Dickinson Company, Biomrieux Sa, Bio-Rad Laboratories, Johnson Johnson, Agilent Technologies, Qiagen, Diasorin, Ortho Clinical Diagnostics are the companies included in The Global In Vitro Diagnostics Market.
The reagents type segment was the leading segment with 52.99% overall market share in 2022.
In terms of revenue, Infectious Diseases held a 27.68% share of the total Global In Vitro Diagnostics Market.
The hospital end-user segment held 47.13% market share of total revenue generated in 2022.
North America held the major share of The Global In Vitro Diagnostics Market.
★ Reviews
No reviews yet — be the first!
Rate this report
Global IVD Market Analysis — Table of Contents
Disclaimer: Redacted sample for representative purposes. Charts and data do not depict actual statistics. TOC varies by license selection.
18.6 Future Gross Margin Outlook and Profitability Trends
19.1 Key Takeaways
Here the analyst will summarize the content of entire report and will share his view point on the current industry scenario and how the market is expected to perform in the near future. The points shared by the analyst are based on his/her detailed in-depth understanding of the market during the course of this report study.
You will be provided exclusive rights to interact with the concerned analyst for unlimited time pre purchase as well as post purchase of the report.
19.2 Analyst Point of View
19.3 Assumptions and Acronyms
20.1 Primary Data Collection
20.1.1 Steps for Primary Data Collection
20.1.1.1 Identification of KOL
20.1.2 Backward Integration
20.1.3 Forward Integration
20.1.4 How Primary Research Help Us
20.1.5 Modes of Primary Research
20.2 Secondary Research
20.2.1 How Secondary Research Help Us
20.2.2 Sources of Secondary Research
20.3 Data Validation
20.3.1 Data Triangulation
20.3.2 Top Down & Bottom Up Approach
20.3.3 Cross check KOL Responses with Secondary Data
20.4 Data Representation
Sample Format of Deliverables
The Tables, Graphs/Charts are only for representative purposes and do not depict actual statistics. Purchase full Report access to actual data.
Cognitive Market Research employs "The Full Truth™" methodology — a rigorous triangulation process that combines primary research, secondary validation, and expert calibration. Implemented by Supriya Yadav and team for the Global IVD Market Analysis Market analysis.
01
Primary Intelligence Gathering
Direct interviews with 50+ industry stakeholders including manufacturers, distributors, end-users, and regulatory bodies across all six regions.
02
Secondary Data Triangulation
Cross-referencing against trade databases, customs records, financial filings, patent databases, and verified industry publications.
03
Expert Validation Protocol
Each data point undergoes validation by minimum two independent domain experts with 15+ years of industry experience.
04
Athenaeum AI Processing
Our proprietary AI platform aggregates, normalizes, and identifies patterns across 10,000+ data points to surface non-obvious insights.
05
Editorial & QA Review
Final review by senior analysts ensures accuracy, coherence, and actionability of all insights and recommendations.
To maintain the integrity of our proprietary methodology and protect our elite expert network, specific source disclosures are reserved for full-access partners. Our research framework is anchored by a 70:30 primary-to-secondary ratio, ensuring your strategy is driven by real-time market intelligence rather than recycled, publicly available, or AI-generated data. Every deliverable includes an exhaustive source directory and grants direct analyst access.
Latest News about IVD Market
Sources from Medical Devices & Consumables Industry
We don't just hand over data. We partner with your team across three integrated service lines — each designed to give you decision-grade intelligence on the Global IVD Market Analysis market.
Service 01
Market Survey
B2BB2C
Structured primary research across both B2B and B2C channels. We design and execute custom surveys targeting manufacturers, distributors, procurement heads, and end-consumers in the global ivd market analysis ecosystem — validated by our global panel of 10,000+ industrial respondents.
What's Included
Buyer intent & sentiment analysis
Purchase cycle mapping
Price sensitivity research
Channel preference profiling
Competitive perception study
Most Requested
Service 02
Customized Market Data & Reports
CustomReady Report
Choose from our ready-to-access 8th Edition report or commission a fully customized dataset tailored to your exact strategic questions. Cross-splits, custom geographies, proprietary segmentation — we build the intelligence asset your board actually needs.
What's Included
Ready syndicate report (250+ pages)
Custom data scope & segmentation
Excel quantitative models
Board-ready PPT with key findings
Secure cloud portal access
Service 03
Strategic Consultation
With SurveyWith Report
Every survey and every report comes with dedicated analyst consultation. Our senior research team walks your leadership through findings, answers strategic questions in real-time, and helps translate data into your next board presentation or investment thesis.
What's Included
Dedicated analyst assigned to you
Live walkthrough of findings
Strategic Q&A sessions
Go-to-market recommendations
NDA-protected engagement
Customize This Report
Tell us the specific segments, regions, or companies you need — and we will tailor the deliverable to your requirements.
